| Year |
Citation |
Score |
| 2014 |
Tourette C, Farina F, Vazquez-Manrique RP, Orfila AM, Voisin J, Hernandez S, Offner N, Parker JA, Menet S, Kim J, Lyu J, Choi SH, Cormier K, Edgerly CK, Bordiuk OL, ... ... Ferrante RJ, et al. The Wnt receptor Ryk reduces neuronal and cell survival capacity by repressing FOXO activity during the early phases of mutant huntingtin pathogenicity. Plos Biology. 12: e1001895. PMID 24960609 DOI: 10.1371/Journal.Pbio.1001895 |
0.323 |
|
| 2014 |
Tourette C, Farina F, Vazquez-Manrique R, Orfila A, Voisin J, Hernandez S, Offner N, Parker J, Menet S, Kim J, Lyu J, Choi S, Cormier K, Edgerly C, Bordiuk O, ... ... Ferrante R, et al. B19 The Wnt Receptor Ryk Reduces Neuronal Resistance Capacity By Repressing Foxo Activity During The Early Phases Of Huntingtin Pathogenicity Journal of Neurology, Neurosurgery & Psychiatry. 85: A15-A15. DOI: 10.1136/Jnnp-2014-309032.47 |
0.301 |
|
| 2013 |
Thomas B, Matson S, Chopra V, Sun L, Sharma S, Hersch S, Rosas HD, Scherzer C, Ferrante R, Matson W. A novel method for detecting 7-methyl guanine reveals aberrant methylation levels in Huntington disease. Analytical Biochemistry. 436: 112-20. PMID 23416183 DOI: 10.1016/J.Ab.2013.01.035 |
0.306 |
|
| 2013 |
Taylor DM, Moser R, Régulier E, Breuillaud L, Dixon M, Beesen AA, Elliston L, Silva Santos Mde F, Kim J, Jones L, Goldstein DR, Ferrante RJ, Luthi-Carter R. MAP kinase phosphatase 1 (MKP-1/DUSP1) is neuroprotective in Huntington's disease via additive effects of JNK and p38 inhibition. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 2313-25. PMID 23392662 DOI: 10.1523/Jneurosci.4965-11.2013 |
0.374 |
|
| 2012 |
Wright PD, Wightman N, Huang M, Weiss A, Sapp PC, Cuny GD, Ivinson AJ, Glicksman MA, Ferrante RJ, Matson W, Matson S, Brown RH. A high-throughput screen to identify inhibitors of SOD1 transcription. Frontiers in Bioscience (Elite Edition). 4: 2801-8. PMID 22652679 DOI: 10.2741/E584 |
0.365 |
|
| 2011 |
Wang X, Sirianni A, Pei Z, Cormier K, Smith K, Jiang J, Zhou S, Wang H, Zhao R, Yano H, Kim JE, Li W, Kristal BS, Ferrante RJ, Friedlander RM. The melatonin MT1 receptor axis modulates mutant Huntingtin-mediated toxicity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 14496-507. PMID 21994366 DOI: 10.1523/Jneurosci.3059-11.2011 |
0.378 |
|
| 2011 |
Hu Y, Chopra V, Chopra R, Locascio JJ, Liao Z, Ding H, Zheng B, Matson WR, Ferrante RJ, Rosas HD, Hersch SM, Scherzer CR. Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouse. Proceedings of the National Academy of Sciences of the United States of America. 108: 17141-6. PMID 21969577 DOI: 10.1073/Pnas.1104409108 |
0.326 |
|
| 2011 |
Xia G, Benmohamed R, Kim J, Arvanites AC, Morimoto RI, Ferrante RJ, Kirsch DR, Silverman RB. Pyrimidine-2,4,6-trione derivatives and their inhibition of mutant SOD1-dependent protein aggregation. Toward a treatment for amyotrophic lateral sclerosis. Journal of Medicinal Chemistry. 54: 2409-21. PMID 21375347 DOI: 10.1021/Jm101549K |
0.345 |
|
| 2011 |
Benmohamed R, Arvanites AC, Kim J, Ferrante RJ, Silverman RB, Morimoto RI, Kirsch DR. Identification of compounds protective against G93A-SOD1 toxicity for the treatment of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 12: 87-96. PMID 21073276 DOI: 10.3109/17482968.2010.522586 |
0.329 |
|
| 2010 |
Kim J, Moody JP, Edgerly CK, Bordiuk OL, Cormier K, Smith K, Beal MF, Ferrante RJ. Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease. Human Molecular Genetics. 19: 3919-35. PMID 20660112 DOI: 10.1093/Hmg/Ddq306 |
0.323 |
|
| 2010 |
Amante DJ, Kim J, Carreiro ST, Cooper AC, Jones SW, Li T, Moody JP, Edgerly CK, Bordiuk OL, Cormier K, Smith K, Ferrante RJ, Rusche J. Uridine ameliorates the pathological phenotype in transgenic G93A-ALS mice. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 11: 520-30. PMID 20565334 DOI: 10.3109/17482968.2010.491867 |
0.37 |
|
| 2010 |
Faideau M, Kim J, Cormier K, Gilmore R, Welch M, Auregan G, Dufour N, Guillermier M, Brouillet E, Hantraye P, Déglon N, Ferrante RJ, Bonvento G. In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects. Human Molecular Genetics. 19: 3053-67. PMID 20494921 DOI: 10.1093/Hmg/Ddq212 |
0.395 |
|
| 2010 |
Kim J, Amante DJ, Moody JP, Edgerly CK, Bordiuk OL, Smith K, Matson SA, Matson WR, Scherzer CR, Rosas HD, Hersch SM, Ferrante RJ. Reduced creatine kinase as a central and peripheral biomarker in Huntington's disease. Biochimica Et Biophysica Acta. 1802: 673-81. PMID 20460152 DOI: 10.1016/J.Bbadis.2010.05.001 |
0.39 |
|
| 2009 |
Yang L, Calingasan NY, Wille EJ, Cormier K, Smith K, Ferrante RJ, Beal MF. Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases. Journal of Neurochemistry. 109: 1427-39. PMID 19476553 DOI: 10.1111/J.1471-4159.2009.06074.X |
0.461 |
|
| 2009 |
Ferrante RJ. Mouse models of Huntington's disease and methodological considerations for therapeutic trials. Biochimica Et Biophysica Acta. 1792: 506-20. PMID 19362590 DOI: 10.1016/J.Bbadis.2009.04.001 |
0.392 |
|
| 2009 |
Noh JY, Lee H, Song S, Kim NS, Im W, Kim M, Seo H, Chung CW, Chang JW, Ferrante RJ, Yoo YJ, Ryu H, Jung YK. SCAMP5 links endoplasmic reticulum stress to the accumulation of expanded polyglutamine protein aggregates via endocytosis inhibition. The Journal of Biological Chemistry. 284: 11318-25. PMID 19240033 DOI: 10.1074/Jbc.M807620200 |
0.351 |
|
| 2009 |
Lee J, Kannagi M, Ferrante RJ, Kowall NW, Ryu H. Activation of Ets-2 by oxidative stress induces Bcl-xL expression and accounts for glial survival in amyotrophic lateral sclerosis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 1739-49. PMID 19179380 DOI: 10.1096/Fj.08-121046 |
0.551 |
|
| 2009 |
Del Signore SJ, Amante DJ, Kim J, Stack EC, Goodrich S, Cormier K, Smith K, Cudkowicz ME, Ferrante RJ. Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 10: 85-94. PMID 18618304 DOI: 10.1080/17482960802226148 |
0.35 |
|
| 2008 |
Stack EC, Matson WR, Ferrante RJ. Evidence of oxidant damage in Huntington's disease: translational strategies using antioxidants. Annals of the New York Academy of Sciences. 1147: 79-92. PMID 19076433 DOI: 10.1196/Annals.1427.008 |
0.369 |
|
| 2008 |
Wang X, Zhu S, Pei Z, Drozda M, Stavrovskaya IG, Del Signore SJ, Cormier K, Shimony EM, Wang H, Ferrante RJ, Kristal BS, Friedlander RM. Inhibitors of cytochrome c release with therapeutic potential for Huntington's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 9473-85. PMID 18799679 DOI: 10.1523/Jneurosci.1867-08.2008 |
0.301 |
|
| 2008 |
Lee J, Hagerty S, Cormier KA, Kim J, Kung AL, Ferrante RJ, Ryu H. Monoallele deletion of CBP leads to pericentromeric heterochromatin condensation through ESET expression and histone H3 (K9) methylation. Human Molecular Genetics. 17: 1774-82. PMID 18319327 DOI: 10.1093/Hmg/Ddn067 |
0.329 |
|
| 2008 |
Stack EC, Ferro JL, Kim J, Del Signore SJ, Goodrich S, Matson S, Hunt BB, Cormier K, Smith K, Matson WR, Ryu H, Ferrante RJ. Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin models of Parkinson's disease. Biochimica Et Biophysica Acta. 1782: 151-62. PMID 18206128 DOI: 10.1016/J.Bbadis.2007.12.006 |
0.392 |
|
| 2008 |
Lee J, Sharma S, Kim J, Ferrante RJ, Ryu H. Mitochondrial nuclear receptors and transcription factors: who's minding the cell? Journal of Neuroscience Research. 86: 961-71. PMID 18041090 DOI: 10.1002/Jnr.21564 |
0.313 |
|
| 2007 |
Klein AM, Ferrante RJ. The neuroprotective role of creatine. Sub-Cellular Biochemistry. 46: 205-43. PMID 18652079 DOI: 10.1007/978-1-4020-6486-9_11 |
0.387 |
|
| 2007 |
Stack EC, Ferrante RJ. Huntington's disease: progress and potential in the field. Expert Opinion On Investigational Drugs. 16: 1933-53. PMID 18042002 DOI: 10.1517/13543784.16.12.1933 |
0.415 |
|
| 2007 |
Stack EC, Dedeoglu A, Smith KM, Cormier K, Kubilus JK, Bogdanov M, Matson WR, Yang L, Jenkins BG, Luthi-Carter R, Kowall NW, Hersch SM, Beal MF, Ferrante RJ. Neuroprotective effects of synaptic modulation in Huntington's disease R6/2 mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 12908-15. PMID 18032664 DOI: 10.1523/Jneurosci.4318-07.2007 |
0.616 |
|
| 2007 |
Wang H, Guan Y, Wang X, Smith K, Cormier K, Zhu S, Stavrovskaya IG, Huo C, Ferrante RJ, Kristal BS, Friedlander RM. Nortriptyline delays disease onset in models of chronic neurodegeneration. The European Journal of Neuroscience. 26: 633-41. PMID 17686041 DOI: 10.1111/J.1460-9568.2007.05663.X |
0.395 |
|
| 2007 |
Kuhn A, Goldstein DR, Hodges A, Strand AD, Sengstag T, Kooperberg C, Becanovic K, Pouladi MA, Sathasivam K, Cha JH, Hannan AJ, Hayden MR, Leavitt BR, Dunnett SB, Ferrante RJ, et al. Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Human Molecular Genetics. 16: 1845-61. PMID 17519223 DOI: 10.1093/Hmg/Ddm133 |
0.366 |
|
| 2007 |
Huang QY, Yu L, Ferrante RJ, Chen JF. Mutant SOD1G93A in bone marrow-derived cells exacerbates 3-nitropropionic acid induced striatal damage in mice. Neuroscience Letters. 418: 175-80. PMID 17418947 DOI: 10.1016/J.Neulet.2007.03.038 |
0.34 |
|
| 2007 |
Stack EC, Del Signore SJ, Luthi-Carter R, Soh BY, Goldstein DR, Matson S, Goodrich S, Markey AL, Cormier K, Hagerty SW, Smith K, Ryu H, Ferrante RJ. Modulation of nucleosome dynamics in Huntington's disease. Human Molecular Genetics. 16: 1164-75. PMID 17403718 DOI: 10.1093/Hmg/Ddm064 |
0.336 |
|
| 2007 |
Ryu H, Ferrante RJ. Translational therapeutic strategies in amyotrophic lateral sclerosis. Mini Reviews in Medicinal Chemistry. 7: 141-50. PMID 17305588 DOI: 10.2174/138955707779802570 |
0.399 |
|
| 2006 |
Ryu H, Lee J, Hagerty SW, Soh BY, McAlpin SE, Cormier KA, Smith KM, Ferrante RJ. ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease. Proceedings of the National Academy of Sciences of the United States of America. 103: 19176-81. PMID 17142323 DOI: 10.1073/Pnas.0606373103 |
0.338 |
|
| 2006 |
Lee J, Kosaras B, Aleyasin H, Han JA, Park DS, Ratan RR, Kowall NW, Ferrante RJ, Lee SW, Ryu H. Role of cyclooxygenase-2 induction by transcription factor Sp1 and Sp3 in neuronal oxidative and DNA damage response. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 2375-7. PMID 17012241 DOI: 10.1096/Fj.06-5957Fje |
0.561 |
|
| 2006 |
Smith KM, Matson S, Matson WR, Cormier K, Del Signore SJ, Hagerty SW, Stack EC, Ryu H, Ferrante RJ. Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice. Biochimica Et Biophysica Acta. 1762: 616-26. PMID 16647250 DOI: 10.1016/J.Bbadis.2006.03.004 |
0.338 |
|
| 2006 |
Qiu Z, Norflus F, Singh B, Swindell MK, Buzescu R, Bejarano M, Chopra R, Zucker B, Benn CL, DiRocco DP, Cha JH, Ferrante RJ, Hersch SM. Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is neuroprotective. The Journal of Biological Chemistry. 281: 16672-80. PMID 16595660 DOI: 10.1074/Jbc.M511648200 |
0.412 |
|
| 2006 |
Hersch SM, Gevorkian S, Marder K, Moskowitz C, Feigin A, Cox M, Como P, Zimmerman C, Lin M, Zhang L, Ulug AM, Beal MF, Matson W, Bogdanov M, Ebbel E, ... ... Ferrante R, et al. Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG. Neurology. 66: 250-2. PMID 16434666 DOI: 10.1212/01.Wnl.0000194318.74946.B6 |
0.31 |
|
| 2006 |
Stack EC, Smith KM, Ryu H, Cormier K, Chen M, Hagerty SW, Del Signore SJ, Cudkowicz ME, Friedlander RM, Ferrante RJ. Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice. Biochimica Et Biophysica Acta. 1762: 373-80. PMID 16364609 DOI: 10.1016/J.Bbadis.2005.11.002 |
0.359 |
|
| 2006 |
Klivenyi P, Siwek D, Gardian G, Yang L, Starkov A, Cleren C, Ferrante RJ, Kowall NW, Abeliovich A, Beal MF. Mice lacking alpha-synuclein are resistant to mitochondrial toxins. Neurobiology of Disease. 21: 541-8. PMID 16298531 DOI: 10.1016/J.Nbd.2005.08.018 |
0.57 |
|
| 2006 |
Stack E, Ferrante R, Siwek D, Kowall N, Morin P. P1-011: Neurogenesis is increased in retrosplenial cortex of six month-old Tg2576 mice Alzheimer's & Dementia. 2: S97-S97. DOI: 10.1016/J.Jalz.2006.05.386 |
0.444 |
|
| 2005 |
Lee J, Kim CH, Simon DK, Aminova LR, Andreyev AY, Kushnareva YE, Murphy AN, Lonze BE, Kim KS, Ginty DD, Ferrante RJ, Ryu H, Ratan RR. Mitochondrial cyclic AMP response element-binding protein (CREB) mediates mitochondrial gene expression and neuronal survival. The Journal of Biological Chemistry. 280: 40398-401. PMID 16207717 DOI: 10.1074/Jbc.C500140200 |
0.322 |
|
| 2005 |
Ryu H, Lee J, Impey S, Ratan RR, Ferrante RJ. Antioxidants modulate mitochondrial PKA and increase CREB binding to D-loop DNA of the mitochondrial genome in neurons. Proceedings of the National Academy of Sciences of the United States of America. 102: 13915-20. PMID 16169904 DOI: 10.1073/Pnas.0502878102 |
0.352 |
|
| 2005 |
Jenkins BG, Andreassen OA, Dedeoglu A, Leavitt B, Hayden M, Borchelt D, Ross CA, Ferrante RJ, Beal MF. Effects of CAG repeat length, HTT protein length and protein context on cerebral metabolism measured using magnetic resonance spectroscopy in transgenic mouse models of Huntington's disease. Journal of Neurochemistry. 95: 553-62. PMID 16135087 DOI: 10.1111/J.1471-4159.2005.03411.X |
0.358 |
|
| 2005 |
Stack EC, Kubilus JK, Smith K, Cormier K, Del Signore SJ, Guelin E, Ryu H, Hersch SM, Ferrante RJ. Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice. The Journal of Comparative Neurology. 490: 354-70. PMID 16127709 DOI: 10.1002/Cne.20680 |
0.378 |
|
| 2005 |
Ryu H, Rosas HD, Hersch SM, Ferrante RJ. The therapeutic role of creatine in Huntington's disease. Pharmacology & Therapeutics. 108: 193-207. PMID 16055197 DOI: 10.1016/J.Pharmthera.2005.04.008 |
0.399 |
|
| 2005 |
Ryu H, Smith K, Camelo SI, Carreras I, Lee J, Iglesias AH, Dangond F, Cormier KA, Cudkowicz ME, Brown RH, Ferrante RJ. Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice. Journal of Neurochemistry. 93: 1087-98. PMID 15934930 DOI: 10.1111/J.1471-4159.2005.03077.X |
0.353 |
|
| 2005 |
Ryu H, Ferrante RJ. Emerging chemotherapeutic strategies for Huntington's disease. Expert Opinion On Emerging Drugs. 10: 345-63. PMID 15934871 DOI: 10.1517/14728214.10.2.345 |
0.411 |
|
| 2005 |
Camelo S, Iglesias AH, Hwang D, Due B, Ryu H, Smith K, Gray SG, Imitola J, Duran G, Assaf B, Langley B, Khoury SJ, Stephanopoulos G, De Girolami U, Ratan RR, ... Ferrante RJ, et al. Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 164: 10-21. PMID 15885809 DOI: 10.1016/J.Jneuroim.2005.02.022 |
0.315 |
|
| 2005 |
Gardian G, Browne SE, Choi DK, Klivenyi P, Gregorio J, Kubilus JK, Ryu H, Langley B, Ratan RR, Ferrante RJ, Beal MF. Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease. The Journal of Biological Chemistry. 280: 556-63. PMID 15494404 DOI: 10.1074/Jbc.M410210200 |
0.402 |
|
| 2004 |
Hersch SM, Ferrante RJ. Translating therapies for Huntington's disease from genetic animal models to clinical trials. Neurorx : the Journal of the American Society For Experimental Neurotherapeutics. 1: 298-306. PMID 15717031 DOI: 10.1602/Neurorx.1.3.298 |
0.318 |
|
| 2004 |
Ferrante RJ, Ryu H, Kubilus JK, D'Mello S, Sugars KL, Lee J, Lu P, Smith K, Browne S, Beal MF, Kristal BS, Stavrovskaya IG, Hewett S, Rubinsztein DC, Langley B, et al. Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 10335-42. PMID 15548647 DOI: 10.1523/Jneurosci.2599-04.2004 |
0.385 |
|
| 2004 |
Norflus F, Nanje A, Gutekunst CA, Shi G, Cohen J, Bejarano M, Fox J, Ferrante RJ, Hersch SM. Anti-inflammatory treatment with acetylsalicylate or rofecoxib is not neuroprotective in Huntington's disease transgenic mice. Neurobiology of Disease. 17: 319-25. PMID 15474369 DOI: 10.1016/J.Nbd.2004.07.011 |
0.343 |
|
| 2004 |
Fox JH, Barber DS, Singh B, Zucker B, Swindell MK, Norflus F, Buzescu R, Chopra R, Ferrante RJ, Kazantsev A, Hersch SM. Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation. Journal of Neurochemistry. 91: 413-22. PMID 15447674 DOI: 10.1111/J.1471-4159.2004.02726.X |
0.392 |
|
| 2004 |
Zhu S, Li M, Figueroa BE, Liu A, Stavrovskaya IG, Pasinelli P, Beal MF, Brown RH, Kristal BS, Ferrante RJ, Friedlander RM. Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 5909-12. PMID 15229238 DOI: 10.1523/Jneurosci.1278-04.2004 |
0.348 |
|
| 2004 |
Beal MF, Ferrante RJ. Experimental therapeutics in transgenic mouse models of Huntington's disease. Nature Reviews. Neuroscience. 5: 373-84. PMID 15100720 DOI: 10.1038/Nrn1386 |
0.367 |
|
| 2004 |
Fink JS, Kalda A, Ryu H, Stack EC, Schwarzschild MA, Chen JF, Ferrante RJ. Genetic and pharmacological inactivation of the adenosine A2A receptor attenuates 3-nitropropionic acid-induced striatal damage. Journal of Neurochemistry. 88: 538-44. PMID 14720203 DOI: 10.1046/J.1471-4159.2003.02145.X |
0.344 |
|
| 2003 |
Andreassen OA, Ferrante RJ, Aamo TO, Beal MF, Jørgensen HA. Oral dyskinesias and histopathological alterations in substantia nigra after long-term haloperidol treatment of old rats. Neuroscience. 122: 717-25. PMID 14622915 DOI: 10.1016/J.Neuroscience.2003.08.058 |
0.324 |
|
| 2003 |
Ferrante RJ, Kubilus JK, Lee J, Ryu H, Beesen A, Zucker B, Smith K, Kowall NW, Ratan RR, Luthi-Carter R, Hersch SM. Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 9418-27. PMID 14561870 DOI: 10.1523/Jneurosci.23-28-09418.2003 |
0.584 |
|
| 2003 |
Clement AM, Nguyen MD, Roberts EA, Garcia ML, Boillée S, Rule M, McMahon AP, Doucette W, Siwek D, Ferrante RJ, Brown RH, Julien JP, Goldstein LS, Cleveland DW. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science (New York, N.Y.). 302: 113-7. PMID 14526083 DOI: 10.1126/Science.1086071 |
0.396 |
|
| 2003 |
Zhang Y, Li M, Drozda M, Chen M, Ren S, Mejia Sanchez RO, Leavitt BR, Cattaneo E, Ferrante RJ, Hayden MR, Friedlander RM. Depletion of wild-type huntingtin in mouse models of neurologic diseases. Journal of Neurochemistry. 87: 101-6. PMID 12969257 DOI: 10.1046/J.1471-4159.2003.01980.X |
0.391 |
|
| 2003 |
Wang X, Zhu S, Drozda M, Zhang W, Stavrovskaya IG, Cattaneo E, Ferrante RJ, Kristal BS, Friedlander RM. Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease. Proceedings of the National Academy of Sciences of the United States of America. 100: 10483-7. PMID 12930891 DOI: 10.1073/Pnas.1832501100 |
0.319 |
|
| 2003 |
Blackshaw S, Eliasson MJ, Sawa A, Watkins CC, Krug D, Gupta A, Arai T, Ferrante RJ, Snyder SH. Species, strain and developmental variations in hippocampal neuronal and endothelial nitric oxide synthase clarify discrepancies in nitric oxide-dependent synaptic plasticity. Neuroscience. 119: 979-90. PMID 12831857 DOI: 10.1016/S0306-4522(03)00217-3 |
0.345 |
|
| 2003 |
Klivenyi P, Ferrante RJ, Gardian G, Browne S, Chabrier PE, Beal MF. Increased survival and neuroprotective effects of BN82451 in a transgenic mouse model of Huntington's disease. Journal of Neurochemistry. 86: 267-72. PMID 12807446 DOI: 10.1046/J.1471-4159.2003.T01-1-01868.X |
0.447 |
|
| 2003 |
Dedeoglu A, Kubilus JK, Yang L, Ferrante KL, Hersch SM, Beal MF, Ferrante RJ. Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice. Journal of Neurochemistry. 85: 1359-67. PMID 12787055 DOI: 10.1046/J.1471-4159.2003.01706.X |
0.379 |
|
| 2003 |
Ryu H, Lee J, Zaman K, Kubilis J, Ferrante RJ, Ross BD, Neve R, Ratan RR. Sp1 and Sp3 are oxidative stress-inducible, antideath transcription factors in cortical neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 3597-606. PMID 12736330 DOI: 10.1523/Jneurosci.23-09-03597.2003 |
0.367 |
|
| 2003 |
Ryu H, Lee J, Olofsson BA, Mwidau A, Dedeoglu A, Escudero M, Flemington E, Azizkhan-Clifford J, Ferrante RJ, Ratan RR, Deodoglu A. Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway. Proceedings of the National Academy of Sciences of the United States of America. 100: 4281-6. PMID 12640146 DOI: 10.1073/Pnas.0737363100 |
0.341 |
|
| 2003 |
Holbert S, Dedeoglu A, Humbert S, Saudou F, Ferrante RJ, Néri C. Cdc42-interacting protein 4 binds to huntingtin: neuropathologic and biological evidence for a role in Huntington's disease. Proceedings of the National Academy of Sciences of the United States of America. 100: 2712-7. PMID 12604778 DOI: 10.1073/Pnas.0437967100 |
0.392 |
|
| 2003 |
Klivenyi P, Ferrante RJ, Gardian G, Browne S, Chabrier PE, Beal MF. Erratum: Increased survival and neuroprotective effects of BN82451 in a transgenic mouse model of Huntington's disease (Journal of Neurochemistry (2003) 86 (267-272)) Journal of Neurochemistry. 87. DOI: 10.1046/J.1471-4159.2003.01868.X |
0.361 |
|
| 2002 |
Dedeoglu A, Kubilus JK, Jeitner TM, Matson SA, Bogdanov M, Kowall NW, Matson WR, Cooper AJ, Ratan RR, Beal MF, Hersch SM, Ferrante RJ. Therapeutic effects of cystamine in a murine model of Huntington's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 8942-50. PMID 12388601 DOI: 10.1523/Jneurosci.22-20-08942.2002 |
0.602 |
|
| 2002 |
Kiechle T, Dedeoglu A, Kubilus J, Kowall NW, Beal MF, Friedlander RM, Hersch SM, Ferrante RJ. Cytochrome C and caspase-9 expression in Huntington's disease. Neuromolecular Medicine. 1: 183-95. PMID 12095160 DOI: 10.1385/Nmm:1:3:183 |
0.58 |
|
| 2002 |
Dedeoglu A, Ferrante RJ, Andreassen OA, Dillmann WH, Beal MF. Mice overexpressing 70-kDa heat shock protein show increased resistance to malonate and 3-nitropropionic acid. Experimental Neurology. 176: 262-5. PMID 12093104 DOI: 10.1006/Exnr.2002.7933 |
0.354 |
|
| 2002 |
Rosas HD, Liu AK, Hersch S, Glessner M, Ferrante RJ, Salat DH, van der Kouwe A, Jenkins BG, Dale AM, Fischl B. Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology. 58: 695-701. PMID 11889230 DOI: 10.1212/Wnl.58.5.695 |
0.335 |
|
| 2002 |
Ferrante RJ, Andreassen OA, Dedeoglu A, Ferrante KL, Jenkins BG, Hersch SM, Beal MF. Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 1592-9. PMID 11880489 DOI: 10.1523/Jneurosci.22-05-01592.2002 |
0.361 |
|
| 2001 |
Bogdanov MB, Andreassen OA, Dedeoglu A, Ferrante RJ, Beal MF. Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease. Journal of Neurochemistry. 79: 1246-9. PMID 11752065 DOI: 10.1046/J.1471-4159.2001.00689.X |
0.384 |
|
| 2001 |
Andreassen OA, Ferrante RJ, Dedeoglu A, Beal MF. Lipoic acid improves survival in transgenic mouse models of Huntington's disease. Neuroreport. 12: 3371-3. PMID 11711888 DOI: 10.1097/00001756-200110290-00044 |
0.369 |
|
| 2001 |
Ferrante RJ, Klein AM, Dedeoglu A, Beal MF. Therapeutic efficacy of EGb761 (Gingko biloba extract) in a transgenic mouse model of amyotrophic lateral sclerosis. Journal of Molecular Neuroscience : Mn. 17: 89-96. PMID 11665866 DOI: 10.1385/Jmn:17:1:89 |
0.349 |
|
| 2001 |
Andreassen OA, Ferrante RJ, Huang HM, Dedeoglu A, Park L, Ferrante KL, Kwon J, Borchelt DR, Ross CA, Gibson GE, Beal MF. Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington's disease. Annals of Neurology. 50: 112-7. PMID 11456300 DOI: 10.1002/Ana.1085 |
0.415 |
|
| 2001 |
Andreassen OA, Dedeoglu A, Ferrante RJ, Jenkins BG, Ferrante KL, Thomas M, Friedlich A, Browne SE, Schilling G, Borchelt DR, Hersch SM, Ross CA, Beal MF. Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease. Neurobiology of Disease. 8: 479-91. PMID 11447996 DOI: 10.1006/Nbdi.2001.0406 |
0.366 |
|
| 2001 |
Andreassen OA, Ferrante RJ, Klivenyi P, Klein AM, Dedeoglu A, Albers DS, Kowall NW, Beal MF. Transgenic ALS mice show increased vulnerability to the mitochondrial toxins MPTP and 3-nitropropionic acid. Experimental Neurology. 168: 356-63. PMID 11259123 DOI: 10.1006/Exnr.2001.7627 |
0.579 |
|
| 2001 |
Holbert S, Denghien I, Kiechle T, Rosenblatt A, Wellington C, Hayden MR, Margolis RL, Ross CA, Dausset J, Ferrante RJ, Néri C. The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis. Proceedings of the National Academy of Sciences of the United States of America. 98: 1811-6. PMID 11172033 DOI: 10.1073/Pnas.98.4.1811 |
0.314 |
|
| 2001 |
Andreassen OA, Ferrante RJ, Dedeoglu A, Albers DW, Klivenyi P, Carlson EJ, Epstein CJ, Beal MF. Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malonate, 3-nitropropionic acid, and MPTP. Experimental Neurology. 167: 189-95. PMID 11161607 DOI: 10.1006/Exnr.2000.7525 |
0.416 |
|
| 2000 |
Andreassen OA, Ferrante RJ, Hughes DB, Klivenyi P, Dedeoglu A, Ona VO, Friedlander RM, Beal MF. Malonate and 3-nitropropionic acid neurotoxicity are reduced in transgenic mice expressing a caspase-1 dominant-negative mutant. Journal of Neurochemistry. 75: 847-52. PMID 10899963 DOI: 10.1046/J.1471-4159.2000.0750847.X |
0.382 |
|
| 2000 |
Chen M, Ona VO, Li M, Ferrante RJ, Fink KB, Zhu S, Bian J, Guo L, Farrell LA, Hersch SM, Hobbs W, Vonsattel JP, Cha JH, Friedlander RM. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nature Medicine. 6: 797-801. PMID 10888929 DOI: 10.1038/77528 |
0.361 |
|
| 2000 |
Ferrante RJ, Andreassen OA, Jenkins BG, Dedeoglu A, Kuemmerle S, Kubilus JK, Kaddurah-Daouk R, Hersch SM, Beal MF. Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 4389-97. PMID 10844007 DOI: 10.1523/Jneurosci.20-12-04389.2000 |
0.407 |
|
| 2000 |
Klivenyi P, Andreassen OA, Ferrante RJ, Lancelot E, Reif D, Beal MF. Inhibition of neuronal nitric oxide synthase protects against MPTP toxicity. Neuroreport. 11: 1265-8. PMID 10817604 DOI: 10.1097/00001756-200004270-00024 |
0.436 |
|
| 2000 |
Jenkins BG, Klivenyi P, Kustermann E, Andreassen OA, Ferrante RJ, Rosen BR, Beal MF. Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice. Journal of Neurochemistry. 74: 2108-19. PMID 10800956 DOI: 10.1046/J.1471-4159.2000.0742108.X |
0.424 |
|
| 2000 |
Andreassen OA, Ferrante RJ, Klivenyi P, Klein AM, Shinobu LA, Epstein CJ, Beal MF. Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis. Annals of Neurology. 47: 447-55. PMID 10762155 DOI: 10.1002/1531-8249(200004)47:4<447::Aid-Ana7>3.0.Co;2-R |
0.4 |
|
| 2000 |
Kowall NW, Hantraye P, Brouillet E, Beal MF, McKee AC, Ferrante RJ. MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons. Neuroreport. 11: 211-3. PMID 10683860 DOI: 10.1097/00001756-200001170-00041 |
0.49 |
|
| 2000 |
Klivenyi P, Andreassen OA, Ferrante RJ, Dedeoglu A, Mueller G, Lancelot E, Bogdanov M, Andersen JK, Jiang D, Beal MF. Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 1-7. PMID 10627575 DOI: 10.1523/Jneurosci.20-01-00001.2000 |
0.344 |
|
| 2000 |
Kowall NW, Ferrante RJ, McKee AC. The pattern of neurodegeneration in the amygdala in dementia with Lewy bodies differs from that found in Alzheimer's disease Neurobiology of Aging. 21: 54. DOI: 10.1016/S0197-4580(00)82922-X |
0.51 |
|
| 1999 |
Klein AM, Kowall NW, Ferrante RJ. Neurotoxicity and oxidative damage of beta amyloid 1-42 versus beta amyloid 1-40 in the mouse cerebral cortex. Annals of the New York Academy of Sciences. 893: 314-20. PMID 10672257 DOI: 10.1111/J.1749-6632.1999.Tb07845.X |
0.476 |
|
| 1999 |
Kuemmerle S, Gutekunst CA, Klein AM, Li XJ, Li SH, Beal MF, Hersch SM, Ferrante RJ. Huntington aggregates may not predict neuronal death in Huntington's disease. Annals of Neurology. 46: 842-9. PMID 10589536 DOI: 10.1002/1531-8249(199912)46:6<842::Aid-Ana6>3.0.Co;2-O |
0.432 |
|
| 1999 |
Shefner JM, Reaume AG, Flood DG, Scott RW, Kowall NW, Ferrante RJ, Siwek DF, Upton-Rice M, Brown RH. Mice lacking cytosolic copper/zinc superoxide dismutase display a distinctive motor axonopathy. Neurology. 53: 1239-46. PMID 10522879 DOI: 10.1212/Wnl.53.6.1239 |
0.485 |
|
| 1999 |
Hanlon EB, Itzkan I, Dasari RR, Feld MS, Ferrante RJ, McKee AC, Lathi D, Kowall NW. Near-infrared fluorescence spectroscopy detects Alzheimer's disease in vitro. Photochemistry and Photobiology. 70: 236-42. PMID 10461462 DOI: 10.1111/J.1751-1097.1999.Tb07994.X |
0.476 |
|
| 1999 |
Eliasson MJ, Huang Z, Ferrante RJ, Sasamata M, Molliver ME, Snyder SH, Moskowitz MA. Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 5910-8. PMID 10407030 DOI: 10.1523/Jneurosci.19-14-05910.1999 |
0.349 |
|
| 1999 |
Matthews RT, Ferrante RJ, Klivenyi P, Yang L, Klein AM, Mueller G, Kaddurah-Daouk R, Beal MF. Creatine and cyclocreatine attenuate MPTP neurotoxicity. Experimental Neurology. 157: 142-9. PMID 10222117 DOI: 10.1006/Exnr.1999.7049 |
0.408 |
|
| 1999 |
Klevenyi P, Andreassen O, Ferrante RJ, Schleicher JR, Friedlander RM, Beal MF. Transgenic mice expressing a dominant negative mutant interleukin-1beta converting enzyme show resistance to MPTP neurotoxicity. Neuroreport. 10: 635-8. PMID 10208603 DOI: 10.1097/00001756-199902250-00035 |
0.38 |
|
| 1999 |
Ferrante RJ, Hantraye P, Brouillet E, Beal MF. Increased nitrotyrosine immunoreactivity in substantia nigra neurons in MPTP treated baboons is blocked by inhibition of neuronal nitric oxide synthase. Brain Research. 823: 177-82. PMID 10095024 DOI: 10.1016/S0006-8993(99)01166-X |
0.458 |
|
| 1999 |
Gutekunst CA, Li SH, Yi H, Mulroy JS, Kuemmerle S, Jones R, Rye D, Ferrante RJ, Hersch SM, Li XJ. Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 2522-34. PMID 10087066 DOI: 10.1523/Jneurosci.19-07-02522.1999 |
0.388 |
|
| 1999 |
Klivenyi P, Ferrante RJ, Matthews RT, Bogdanov MB, Klein AM, Andreassen OA, Mueller G, Wermer M, Kaddurah-Daouk R, Beal MF. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nature Medicine. 5: 347-50. PMID 10086395 DOI: 10.1038/6568 |
0.381 |
|
| 1999 |
Bogdanov MB, Ferrante RJ, Mueller G, Ramos LE, Martinou JC, Beal MF. Oxidative stress is attenuated in mice overexpressing BCL-2. Neuroscience Letters. 262: 33-6. PMID 10076866 DOI: 10.1016/S0304-3940(99)00047-6 |
0.341 |
|
| 1999 |
Browne SE, Ferrante RJ, Beal MF. Oxidative stress in Huntington's disease. Brain Pathology (Zurich, Switzerland). 9: 147-63. PMID 9989457 DOI: 10.1111/J.1750-3639.1999.Tb00216.X |
0.431 |
|
| 1999 |
Hanlon EB, Itzkan I, Dasari RR, Feld MS, Ferrante RJ, McKee AC, Lathi D, Kowall NW. Near-infrared Fluorescence Spectroscopy Detects Alzheimer's Disease In Vitro Photochemistry and Photobiology. 70: 236-242. DOI: 10.1111/j.1751-1097.1999.tb07994.x |
0.444 |
|
| 1999 |
Boyer PJ, McKee AC, Kowall NW, Vonsattle JP, Klein AM, Ferrante RJ. ALPHA-SYNUCLEIN IMMUNOCHEMISTRY ENHANCES DIAGNOSTIC ACCURACY OF NEUROPATHOLOGIC EXAMINATION OF BRAINS FROM PATIENTS WITH DEMENTIA Journal of Neuropathology and Experimental Neurology. 58: 554. DOI: 10.1097/00005072-199905000-00193 |
0.406 |
|
| 1999 |
Kowall NW, Kuemmerle S, Ferrante RJ. Chapter 3 The Genetic Basis and Molecular Pathogenesis of Huntington's Disease Advances in Cell Aging and Gerontology. 3: 81-92. DOI: 10.1016/S1566-3124(08)60023-1 |
0.582 |
|
| 1998 |
Bogdanov MB, Ferrante RJ, Kuemmerle S, Klivenyi P, Beal MF. Increased vulnerability to 3-nitropropionic acid in an animal model of Huntington's disease. Journal of Neurochemistry. 71: 2642-4. PMID 9832167 DOI: 10.1046/J.1471-4159.1998.71062642.X |
0.383 |
|
| 1998 |
Klivenyi P, Beal MF, Ferrante RJ, Andreassen OA, Wermer M, Chin MR, Bonventre JV. Mice deficient in group IV cytosolic phospholipase A2 are resistant to MPTP neurotoxicity. Journal of Neurochemistry. 71: 2634-7. PMID 9832165 DOI: 10.1046/J.1471-4159.1998.71062634.X |
0.339 |
|
| 1998 |
Andreassen OA, Ferrante RJ, Beal MF, Jørgensen HA. Oral Dyskinesias and striatal lesions in rats after long-term co-treatment with haloperidol and 3-nitropropionic acid. Neuroscience. 87: 639-48. PMID 9758230 DOI: 10.1016/S0306-4522(98)00160-2 |
0.343 |
|
| 1998 |
Gutekunst CA, Li SH, Yi H, Ferrante RJ, Li XJ, Hersch SM. The cellular and subcellular localization of huntingtin-associated protein 1 (HAP1): comparison with huntingtin in rat and human. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 7674-86. PMID 9742138 DOI: 10.1523/Jneurosci.18-19-07674.1998 |
0.332 |
|
| 1998 |
Li SH, Hosseini SH, Gutekunst CA, Hersch SM, Ferrante RJ, Li XJ. A human HAP1 homologue. Cloning, expression, and interaction with huntingtin. The Journal of Biological Chemistry. 273: 19220-7. PMID 9668110 DOI: 10.1074/Jbc.273.30.19220 |
0.303 |
|
| 1998 |
Matthews RT, Yang L, Jenkins BG, Ferrante RJ, Rosen BR, Kaddurah-Daouk R, Beal MF. Neuroprotective Effects of Creatine and Cyclocreatine in Animal Models of Huntington’s Disease The Journal of Neuroscience. 18: 156-163. DOI: 10.1523/Jneurosci.18-01-00156.1998 |
0.36 |
|
| 1998 |
Klein AM, Ferrante RJ, Kowall NW, Matthews RT, McKee AC, Kaddurak-Daouk R, Beal MF. CREATINE AND CYCLOCREATINE ATTENUATE MPTP NEUROTOXICITY Journal of Neuropathology and Experimental Neurology. 57: 510. DOI: 10.1097/00005072-199805000-00183 |
0.539 |
|
| 1997 |
Beal MF, Ferrante RJ, Browne SE, Matthews RT, Kowall NW, Brown RH. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Annals of Neurology. 42: 644-54. PMID 9382477 DOI: 10.1002/ana.410420416 |
0.497 |
|
| 1997 |
Ferrante RJ, Browne SE, Shinobu LA, Bowling AC, Baik MJ, MacGarvey U, Kowall NW, Brown RH, Beal MF. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. Journal of Neurochemistry. 69: 2064-74. PMID 9349552 DOI: 10.1046/J.1471-4159.1997.69052064.X |
0.57 |
|
| 1997 |
Ferrante RJ, Shinobu LA, Schulz JB, Matthews RT, Thomas CE, Kowall NW, Gurney ME, Beal MF. Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation. Annals of Neurology. 42: 326-34. PMID 9307254 DOI: 10.1002/Ana.410420309 |
0.525 |
|
| 1997 |
Ayata C, Ayata G, Hara H, Matthews RT, Beal MF, Ferrante RJ, Endres M, Kim A, Christie RH, Waeber C, Huang PL, Hyman BT, Moskowitz MA. Mechanisms of reduced striatal NMDA excitotoxicity in type I nitric oxide synthase knock-out mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 6908-17. PMID 9278526 DOI: 10.1523/Jneurosci.17-18-06908.1997 |
0.386 |
|
| 1997 |
Matthews RT, Ferrante RJ, Jenkins BG, Browne SE, Goetz K, Berger S, Chen IY, Beal MF. Iodoacetate produces striatal excitotoxic lesions. Journal of Neurochemistry. 69: 285-9. PMID 9202321 DOI: 10.1046/J.1471-4159.1997.69010285.X |
0.374 |
|
| 1997 |
Ferrante RJ, Schulz JB, Kowall NW, Beal MF. Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra. Brain Research. 753: 157-62. PMID 9125443 DOI: 10.1016/S0006-8993(97)00008-5 |
0.545 |
|
| 1997 |
Ferrante RJ, Gutekunst CA, Persichetti F, McNeil SM, Kowall NW, Gusella JF, MacDonald ME, Beal MF, Hersch SM. Heterogeneous topographic and cellular distribution of huntingtin expression in the normal human neostriatum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 3052-63. PMID 9096140 |
0.554 |
|
| 1997 |
Ferrante RJ, Beal MF, Kowall NW. IMMUNOHISTOCHEMICAL LOCALIZATION OF MARKERS FOR OXIDATIVE INJURY IN PARKINSONʼS DISEASE Journal of Neuropathology and Experimental Neurology. 56: 589. DOI: 10.1097/00005072-199705000-00084 |
0.503 |
|
| 1996 |
Hantraye P, Brouillet E, Ferrante R, Palfi S, Dolan R, Matthews RT, Beal MF. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nature Medicine. 2: 1017-21. PMID 8782460 DOI: 10.1038/nm0996-1017 |
0.358 |
|
| 1996 |
Reaume AG, Elliott JL, Hoffman EK, Kowall NW, Ferrante RJ, Siwek DF, Wilcox HM, Flood DG, Beal MF, Brown RH, Scott RW, Snider WD. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nature Genetics. 13: 43-7. PMID 8673102 DOI: 10.1038/Ng0596-43 |
0.553 |
|
| 1996 |
Palfi S, Ferrante RJ, Brouillet E, Beal MF, Dolan R, Guyot MC, Peschanski M, Hantraye P. Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 3019-25. PMID 8622131 DOI: 10.1523/Jneurosci.16-09-03019.1996 |
0.338 |
|
| 1996 |
Kowall NW, Beal MF, Brown RH, Beckman JS, Volicer L, Ferrante RJ. LOCALIZATION OF MULTIPLE HISTOCHEMICAL MARKERS OF OXIDATIVE INJURY IN PROJECTION NEURONS IN ALZHEIMER CORTEX Journal of Neuropathology and Experimental Neurology. 55: 618. DOI: 10.1097/00005072-199605000-00064 |
0.554 |
|
| 1995 |
Schulz JB, Matthews RT, Jenkins BG, Ferrante RJ, Siwek D, Henshaw DR, Cipolloni PB, Mecocci P, Kowall NW, Rosen BR. Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 8419-29. PMID 8613773 |
0.559 |
|
| 1995 |
Brouillet E, Hantraye P, Ferrante RJ, Dolan R, Leroy-Willig A, Kowall NW, Beal MF. Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proceedings of the National Academy of Sciences of the United States of America. 92: 7105-9. PMID 7624378 DOI: 10.1073/Pnas.92.15.7105 |
0.557 |
|
| 1995 |
Beal MF, Ferrante RJ, Henshaw R, Matthews RT, Chan PH, Kowall NW, Epstein CJ, Schulz JB. 3-Nitropropionic acid neurotoxicity is attenuated in copper/zinc superoxide dismutase transgenic mice. Journal of Neurochemistry. 65: 919-22. PMID 7616254 |
0.497 |
|
| 1995 |
Schulz JB, Henshaw DR, Siwek D, Jenkins BG, Ferrante RJ, Cipolloni PB, Kowall NW, Rosen BR, Beal MF. Involvement of free radicals in excitotoxicity in vivo. Journal of Neurochemistry. 64: 2239-47. PMID 7536809 DOI: 10.1046/J.1471-4159.1995.64052239.X |
0.543 |
|
| 1995 |
Schulz J, Matthews R, Jenkins B, Ferrante R, Siwek D, Henshaw D, Cipolloni P, Mecocci P, Kowall N, Rosen B. Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo The Journal of Neuroscience. 15: 8419-8429. DOI: 10.1523/Jneurosci.15-12-08419.1995 |
0.559 |
|
| 1995 |
Kowall N, Ferrante R, Robert Brown JS, Beal MF. INTRACISTERNAL INFUSION OF SUPEROXIDE DISMUTASE-1 (SOD1) ANTISENSE OLIGODEOXYNUCLEOTIDE CAUSES ANTERIOR HORN CELL DEGENERATION IN VIVO Journal of Neuropathology and Experimental Neurology. 54: 417. DOI: 10.1097/00005072-199505000-00040 |
0.516 |
|
| 1994 |
Henshaw R, Jenkins BG, Schulz JB, Ferrante RJ, Kowall NW, Rosen BR, Beal MF. Malonate produces striatal lesions by indirect NMDA receptor activation. Brain Research. 647: 161-6. PMID 8069700 DOI: 10.1016/0006-8993(94)91412-5 |
0.553 |
|
| 1994 |
Rosen DR, Bowling AC, Patterson D, Usdin TB, Sapp P, Mezey E, McKenna-Yasek D, O'Regan J, Rahmani Z, Ferrante RJ. A frequent ala 4 to val superoxide dismutase-1 mutation is associated with a rapidly progressive familial amyotrophic lateral sclerosis. Human Molecular Genetics. 3: 981-7. PMID 7951249 DOI: 10.1093/Hmg/3.6.981 |
0.335 |
|
| 1994 |
Schulz JB, Henshaw DR, Jenkins BG, Ferrante RJ, Kowall NW, Rosen BR, Beal MF. 3-Acetylpyridine produces age-dependent excitotoxic lesions in rat striatum. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 14: 1024-9. PMID 7929644 DOI: 10.1038/Jcbfm.1994.134 |
0.547 |
|
| 1994 |
Storey E, Cipolloni PB, Ferrante RJ, Kowall NW, Beal MF. Movement disorder following excitotoxin lesions in primates. Neuroreport. 5: 1259-61. PMID 7919178 |
0.451 |
|
| 1993 |
Ferrante RJ, Kowall NW, Cipolloni PB, Storey E, Beal MF. Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterization. Experimental Neurology. 119: 46-71. PMID 8432351 DOI: 10.1006/exnr.1993.1006 |
0.575 |
|
| 1993 |
Brouillet E, Jenkins BG, Hyman BT, Ferrante RJ, Kowall NW, Srivastava R, Roy DS, Rosen BR, Beal MF. Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. Journal of Neurochemistry. 60: 356-9. PMID 8417157 DOI: 10.1111/J.1471-4159.1993.Tb05859.X |
0.542 |
|
| 1993 |
Kowall NW, Quigley BJ, Krause JE, Lu F, Kosofsky BE, Ferrante RJ. Substance P and substance P receptor histochemistry in human neurodegenerative diseases. Regulatory Peptides. 46: 174-85. PMID 7692486 DOI: 10.1016/0167-0115(93)90028-7 |
0.551 |
|
| 1993 |
Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman BT. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 13: 4181-92. PMID 7692009 |
0.516 |
|
| 1993 |
Beal M, Brouillet E, Jenkins B, Ferrante R, Kowall N, Miller J, Storey E, Srivastava R, Rosen B, Hyman B. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid The Journal of Neuroscience. 13: 4181-4192. DOI: 10.1523/Jneurosci.13-10-04181.1993 |
0.516 |
|
| 1993 |
Ferrante RJ, Harrington KM, Evans AJ, Kowall NW. NEURONAL HEAT SHOCK PROTEIN (HSP 72) IMMUNOREACTIVITY IS INCREASED IN THE STRIATUM AND NEOCORTEX IN HUNTINGTONʼS DISEASE Journal of Neuropathology and Experimental Neurology. 52: 292. DOI: 10.1097/00005072-199305000-00129 |
0.554 |
|
| 1991 |
Ferrante RJ, Kowall NW, Richardson EP. Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 11: 3877-87. PMID 1836019 DOI: 10.1523/Jneurosci.11-12-03877.1991 |
0.55 |
|
| 1991 |
Beal MF, Ferrante RJ, Swartz KJ, Kowall NW. Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 11: 1649-59. PMID 1710657 DOI: 10.1523/Jneurosci.11-06-01649.1991 |
0.522 |
|
| 1991 |
Beal M, Ferrante R, Swartz K, Kowall N. Chronic quinolinic acid lesions in rats closely resemble Huntington's disease The Journal of Neuroscience. 11: 1649-1659. DOI: 10.1523/JNEUROSCI.11-06-01649.1991 |
0.474 |
|
| 1990 |
Beal MF, Kowall NW, Swartz KJ, Ferrante RJ. Homocysteic acid lesions in rat striatum spare somatostatin-neuropeptide Y (NADPH-diaphorase) neurons. Neuroscience Letters. 108: 36-42. PMID 1689475 DOI: 10.1016/0304-3940(90)90702-B |
0.529 |
|
| 1989 |
Beal MF, Kowall NW, Swartz KJ, Ferrante RJ, Martin JB. Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions. Synapse (New York, N.Y.). 3: 38-47. PMID 2563916 DOI: 10.1002/Syn.890030106 |
0.636 |
|
| 1989 |
Ferrante RJ, Kowall NW, Richardson EP. NEURONAL AND NEUROPIL LOSS IN THE SUBSTANTIA NIGRA IN HUNTINGTONʼS DISEASE Journal of Neuropathology and Experimental Neurology. 48: 380. DOI: 10.1097/00005072-198905000-00245 |
0.558 |
|
| 1988 |
Beal MF, Kowall NW, Swartz KJ, Ferrante RJ, Martin JB. Response:Model of Huntington's disease. Science (New York, N.Y.). 241: 475. PMID 17792612 DOI: 10.1126/science.241.4864.475 |
0.574 |
|
| 1988 |
Beal MF, Kowall NW, Swartz KJ, Ferrante RJ, Martin JB. Systemic approaches to modifying quinolinic acid striatal lesions in rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 8: 3901-8. PMID 2461437 DOI: 10.1523/Jneurosci.08-10-03901.1988 |
0.594 |
|
| 1988 |
Beal M, Kowall N, Swartz K, Ferrante R, Martin J. Systemic approaches to modifying quinolinic acid striatal lesions in rats The Journal of Neuroscience. 8: 3901-3908. DOI: 10.1523/JNEUROSCI.08-10-03901.1988 |
0.431 |
|
| 1987 |
Ferrante RJ, Beal MF, Kowall NW, Richardson EP, Martin JB. Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease. Brain Research. 411: 162-6. PMID 2955849 DOI: 10.1016/0006-8993(87)90694-9 |
0.684 |
|
| 1987 |
Ferrante RJ, Kowall NW, Beal MF, Martin JB, Bird ED, Richardson EP. Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease. Journal of Neuropathology and Experimental Neurology. 46: 12-27. PMID 2947977 DOI: 10.1097/00005072-198701000-00002 |
0.65 |
|
| 1987 |
Ferrante RJ, Kowall NW. Tyrosine hydroxylase-like immunoreactivity is distributed in the matrix compartment of normal human and Huntington's disease striatum. Brain Research. 416: 141-6. PMID 2887244 DOI: 10.1016/0006-8993(87)91506-X |
0.529 |
|
| 1987 |
Kowall NW, Ferrante RJ, Beal MF, Richardson EP, Sofroniew MV, Cuello AC, Martin JB. Neuropeptide Y, somatostatin, and reduced nicotinamide adenine dinucleotide phosphate diaphorase in the human striatum: a combined immunocytochemical and enzyme histochemical study. Neuroscience. 20: 817-28. PMID 2885780 DOI: 10.1016/0306-4522(87)90242-9 |
0.617 |
|
| 1987 |
Ferrante RJ, Kowall NW, Martin JB, Richardson EP. SUBSTANCE P-CONTAINING STRIATAL NEURONS IN HUNTINGTONʼS DISEASE Journal of Neuropathology and Experimental Neurology. 46: 375. DOI: 10.1097/00005072-198705000-00138 |
0.64 |
|
| 1987 |
Kowall NW, Ferrante RJ, Martin JB. Patterns of cell loss in Huntington's disease Trends in Neurosciences. 10: 24-29. DOI: 10.1016/0166-2236(87)90120-2 |
0.664 |
|
| 1987 |
Kowall NW, Ferrante RJ, Martin JB. Reply from Neil Kowall and colleagues Trends in Neurosciences. 10: 404-406. DOI: 10.1016/0166-2236(87)90007-5 |
0.515 |
|
| 1986 |
Ferrante RJ, Kowall NW, Richardson EP, Bird ED, Martin JB. Topography of enkephalin, substance P and acetylcholinesterase staining in Huntington's disease striatum. Neuroscience Letters. 71: 283-8. PMID 2432445 DOI: 10.1016/0304-3940(86)90634-8 |
0.638 |
|
| 1986 |
Ferrante RJ, Kowall NW, Martin JB, Richardson EP. HISTOCHEMICAL STAINING PATTERNS IN HUNTINGTONʼS DISEASE Journal of Neuropathology and Experimental Neurology. 45: 335. DOI: 10.1097/00005072-198605000-00067 |
0.574 |
|
| 1985 |
Ferrante RJ, Kowall NW, Beal MF, Richardson EP, Bird ED, Martin JB. Selective sparing of a class of striatal neurons in Huntington's disease. Science (New York, N.Y.). 230: 561-3. PMID 2931802 DOI: 10.1126/Science.2931802 |
0.661 |
|
| 1985 |
Kowall NW, Beal MF, Ferrante RJ, Martin JB. Topography of nicotinamide adenine dinucleotide phosphate-diaphorase staining neurons in rat striatum. Neuroscience Letters. 59: 61-6. PMID 2931630 DOI: 10.1016/0304-3940(85)90215-0 |
0.626 |
|
| Show low-probability matches. |